Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,513

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2015

Conditions
Non-small Cell Lung Cancer
Interventions
BIOLOGICAL

Tecemotide (L-BLP25)

After receiving cyclophosphamide, participants will receive 8 consecutive weekly subcutaneous vaccinations with 806 microgram (mcg) of tecemotide (L-BLP25) at Weeks 0, 1, 2, 3, 4, 5, 6, and 7 followed by maintenance vaccinations with 806 mcg of tecemotide (L-BLP25) at 6-week intervals, commencing at Week 13, until disease progression is documented.

DRUG

Single low dose cyclophosphamide

A single intravenous infusion of 300 milligram per square meter (mg/m\^2) (to a maximum 600 mg) of cyclophosphamide will be given 3 days before first tecemotide (L-BLP25) vaccination.

DRUG

Placebo

A single infusion (IV) of 0.9% Saline solution instead of cyclophosphamide but in the same calculated dose will be given three days before first placebo vaccination. Subjects will then receive eight consecutive weekly subcutaneous vaccinations with placebo at weeks 0; 1; 2; 3; 4; 5; 6 and 7 followed by maintenance placebo vaccinations at 6-week intervals, commencing at week 13, until disease progression is documented.

Trial Locations (290)

10011

St. Vincents Comprehensive Cancer Center, New York

10960

Hematology Oncology Associates of Rockland, Nyack

19104

Univ. of Pennsylvania Abramson Cancer Center, Philadelphia

19111

Fox Chase Cancer Center, Philadelphia

21215

Sinai Hospital of Baltimore, Baltimore

22031

Fairfax-Northern Virginia Hematology Oncology, PC, Fairfax

26003

Wheeling Hospital, Wheeling

27599

Univ. of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill

28203

Carolinas Hematology-Oncology, Charlotte

28401

Hanover Medical Specialts PA, Wilmington

32174

Florida Hospital Memorial System, Ormond Beach

34613

Pasco Hernando Oncology Associates P.A, Brooksville

34652

Pasco Hernando Oncology Associates, PA, New Port Richey

38138

The Jones Clinic, PC, Germantown

41701

Kentucky Cancer Center, Hazard

44106

University Hospitals of Cleveland, Cleveland

44718

Gabrail Cancer Center, Canton

45042

Signal Point Clinical Research Center, LLC, Middletown

49085

Oncology Care Associates, Saint Joseph

59101

Deaconess Billings Clinic, Billings

59405

Big Sky Oncology, Sletten Cancer Institute, Great Falls

60435

Joliet Oncology-Hematology Associates, Ltd., Joliet

60612

Rush University Medical Center, Chicago

62801

Southern Illinois Hematology/Oncology, Centralia

68510

Southeast Nebraska Cancer Center, Lincoln

68901

Nebraska Cancer Care, LLC, Hastings

70006

Hematology and Oncology Specialists, LLC, Metarie

72901

Saint Edward Mercy Medical Center, Fort Smith

74133

Southwestern Regional Medical Center, Tulsa

75230

Center for Oncology Research, Dallas

76104

John Peter Smith Center for Cancer Care, Fort Worth

The Center for Cancer and Blood Disorders, Fort Worth

78229

Cancer Therapy & Research Center, Institute for Drug Development, San Antonio

80045

University of Colorado Cancer Center, Denver

90033

Norris Cancer Hospital, Los Angeles

90048

Cedars-Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles

90640

Clinical Trials and Research Associates, Inc., Montebello

91206

Glendale Adventist Medical Center, Glendale

92801

Pacific Cancer Medical Center, Anaheim

95204

Stockton Hematology Oncology Medical Group, Inc., Stockton

97213

Providence Portland Medical Center, Portland

Unknown

Desert Hematology Oncology Medical Group, Inc, Rancho Mirage

University of Miami, Sylvester Comprehensive Cancer Center, Miami

Leonard J. Chabert Medical Center, Houma

University of Maryland, Marlene and Steward Greenbaum Cancer Center, Baltimore

Lahey Clinic, Burlington

University of Minnesota Physicians, Masonic Cancer Center, Minneapolis

Saint Louis University Cance Center, St Louis

Southwestern Regional Medical Center, Tulsa

Hospital Italiano Regional del Sur, Bahía Blanca

Paliar, Capital, Buenos Aires

Corporacion Medica General San Martin, San Martín

Centro Oncologico de Roario, Rosario

"Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno (CEMIC)", Buenos Aires

Instituto Especializado Alexander Fleming, Buenos Aires

Sociedad Intaliana de Beneficencia en Buenos Aires, Hospital Italiano, Buenos Aires

Clinica Universitaria Reina Fabiola, Córdoba

Research Site, Tandil

Research Site, Nedlands

Research Site, Bankstown, NSW

Research Site, Camperdown

Research Site, Heidelberg

Research Site, Kingswood

Research Site, Saint Leonards

Research Site, Woolloongabba

Research Site, Graz

Research Site, Linz

Research Site, Inssbruck

Research Site, Salzburg

Research Site, Vienna

Research Site, Wein, Venna

Research Site, Wels

Research Site, Brasschaat

Research Site, Brussels

Research Site, Haine-Saint-Paul

Research Site, Leuven

Research Site, Liège

Research Site, Mechelen

Hospital das Clinicas da Faculdade de Medinina de Univeridade, São Paulo

Nugieo de Oncologia da Bahia, Salvador

Hospital LifeCenter, Belo Horizonte

Hospital Nossa Senhora da Conceicao, Centro de Pesquisas Medicas e Ensaios Clinicos, Porto Alegre

Associacao Hospital de Caridade Ijui, Ijuí

Hospital de Clinicas de Porto Alegre, Dept. de Endocrinologia, Porto Alegre

Hospital Sao Lucas-Pucrs, Porto Alegre

Research Site, Porto Algre

Centro de Oncologia de Campinas - OCC, Campinas

Fundacao Hospital Amaral Carvalho, Jaú

Instituto do Cancer Arnaldo Vieira de Caralho-Onco-pneumonia, São Paulo

Santa Casa de Misericordia De Sao Paulo, São Paulo

Instituto de Oncologia de Sorocaba, Sorocaba

Research Site, Ondina-Salvdor

Instituto Nacional do Cancer - INCA, Rio de Janeriro

Tom Baker Cancer Center, Calgary

Cross Cancer Institue, Edmonton

Frazer Valley Cancer Center, Surrey

British Columbia Cancer Agency, Vancouver

Vancouver Island Cancer Center, Victoria

Cancer Care Manitoba, Winnipeg

Capital District Health Authority, Halifax

Cape Breton Districk Health Authority Cancer Care, Sydney

Juravinski Cancer Center, Hamilton

Niagara Health System, St. Catharines

Thunder Bay Regional Health Science Center Northwestern Ontario Regional Center, Thunder Bay

Mount Sinai Hospital, Toronto

Princess Margaret Hospital, Toronto

Windsor Regional Cancer Center, Windsor

Hopital Notre Dame, Montreal

Jewish General Hospital, Montreal

Hopital Laval, Sainte-Foy

Research Site, Beijing

Research Site, Guangzhou

Research Site, Shanghai

Research Site, Hradec Králové

Research Site, Ostrava-Poruba

Research Site, Prague

Research Site, Ústí nad Labem

Research Site, Herlev

Research Site, Odense C

Research Site, Pierre-Bénite

Research Site, Besançon

Research Site, Beuvry

Research Site, Brest

Research Site, Caen

Research Site, Chauny

Research Site, Marseille

Research Site, Nancy

Research Site, Nantes-Saint Herblain

Research Site, Paris

Research Site, Perpignan

Research Site, Poitiers

Research Site, Strasbourg

Research Site, Essen

Research Site, Hemer

Research Site, Mainz

Research Site, Homburg

Research Site, Berlin

Research Site, Cologne

Research Site, Coswig

Research Site, Essen

Research Site, Frankfurt am Main

Research Site, Freiburg im Breisgau

Research Site, Gauting

Research Site, Großhansdorf

Research Site, Hamburg

Reseach Site, Heidelberg

Research Site, Kassel

Research Site, Kiel

Research Site, Leipzig

Research Site, Magdeburg

Research Site, Mainz

Research Site, Minden

Research Site, Mutzschen

Research Site, München

Research Site, Oldenburg

Research Site, Rostock

Research Site, Marousi

Research Site, Athens

Research Site, Thessaloniki

Research Site, Athens

Research Site, Chidari, Athens

Research Site, Heraklion

Research Site, Shatin

Research Site, Hong Kong

Research Site, Budapest

Research Site, Mátraháza

Research Site, Nyíregyháza

Research Site, Tatabayana

Research Site, Chennai

Research Site, Hyderabad

Research Site, Mumbai

Research Site, New Delhi

Research Site, Vellore

Research Site, Dublin

Research Site, Tel Litwinsky

Research Site, Beersheba

Research Site, Haifa

Research Site, Jerusalem

Research Site, Kfar Saba

Research Site, Petah Tikva

Research Site, Tel Aviv

Research Site, Ẕerifin

Research Site, Genova

Research Site, Palermo

Research Site, Candiolo

Research Site, Avelino

Research Site, Bologna

Research Site, Carpi

Research Site, Chieti

Research Site, Forlì

Research Site, Meldola

Research Site, Milan

Research Site, Napoli

Research Site, Orbassano-Torino

Research Site, Parma

Research Site, Rome

Research Site, Rozzano-Milano

Research Site, Sassari

Research Site, Trento

Centro Oncologico de Chihuahua, Chihuahua City

Consultorio del, Morelia

Instituto Nacional de Cancerologia (INCAN), Mexico City

Research Site, Amsterdam

Research Site, Amsterdam

Research Site, Eindhoven

Research Site, Hoofdrop

Research Site, Tilburg

Research Site, Zwolle

Research Site, Warsaw

Research Site, Bialystok

Research Site, Bydgoszcz

Research Site, Bytom

Research Site, Gdynia

Research Site, Krakow

Genova, Lodz

Research Site, Olsztyn

Research Site, Otwock

Research Site, Poznan

Research Site, Torun

Genova, Warsaw

Research Site, Warsaw

Research Site, Wroclaw

Research Site, Zabrze

Genova, Coimbra

Genova, Lisbon

Genova, Porto

Genova, Santa Maria de Feira

Research Site, Bucharest

Research Site, Cluj-Napoca

Research Site, Iași

Research Site, Sibiu

Research Site, Suceava

Research Site, Timișoara

Reseaerch Site, Kazan'

Research Site, Yaroslavl

Research Site, Barnaul

Genova, Chelaybinsk

Research Site, Ivanovo

Research Site, Kazan'

Research Site, Moscow

Research Site, Obninsk

Research Site, Saint Petersburg

Research Site, Tomsk

Research Site, Voronezh

Research Site, Singapore

Research Site, Bratislava

Research Site, Košice

Research Site, Nitra

Research Site, Goyang-si

Research Site, Seoul

Research Site, Seoul

Research Site, Mataró

Research Site, Barakaldo

Research Site, Donostia / San Sebastian

Research Site, Jaén

Research Site, A Coruña

Research Site, Alicante

Research Site, Barcelona

Research Site, Burgos

Research Site, Girona

Research Site, Lugo

Research Site, Madrid

Research Site, Málaga

Research Site, Gävle

Research Site, Gothenburg

Research Site, Lund

Research Site, Stockholm

Research Site, Umeå

Research Site, Uppsala

Research Site, Basel

Research Site, Geneva

Research Site, Winterthur

Research Site, Kaohsiung City

Research Site, Taichung

Research Site, Tainan City

Research Site, Taipei

Research Site, Taoyuan District

Research Site, Cornwall

Research Site, Edinburgh

Research Site, Glasgow

Research Site, Guildford

Research Site, Inverness

Research Site, Leeds

Research Site, Leicester

Research Site, London

Research Site, Manchester

Research Site, Metropolitan Borough of Wirral

Research Site, Southampton

Research Site, Surrey

Research Site, Torquay

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Merck KGaA, Darmstadt, Germany

INDUSTRY

lead

EMD Serono

INDUSTRY

NCT00409188 - Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START) | Biotech Hunter | Biotech Hunter